Total Payments
$186.38
2024 Payments
$122.34
Companies
6
Transactions
11
Medicare Patients
619
Medicare Billing
$58,307
Payment Breakdown by Category
Food & Beverage$186.38 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $186.38 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $64.62 | 4 | $0 (2024) |
| Lilly USA, LLC | $41.20 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $33.44 | 2 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $21.64 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $18.34 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122.34 | 7 | ABBVIE INC. ($47.22) |
| 2023 | $17.86 | 1 | Otsuka America Pharmaceutical, Inc. ($17.86) |
| 2022 | $39.04 | 2 | Kowa Pharmaceuticals America, Inc. ($21.64) |
| 2021 | $7.14 | 1 | Genentech USA, Inc. ($7.14) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: PSYCHIATRY | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $21.64 | General |
| Category: Pain Management | ||||||
| 10/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 198 | 536 | $84,980 | $22,194 |
| 2022 | 9 | 220 | 460 | $58,565 | $18,606 |
| 2021 | 2 | 89 | 213 | $15,805 | $8,131 |
| 2020 | 5 | 112 | 227 | $18,935 | $9,375 |
Total Patients
619
Total Services
1,436
Medicare Billing
$58,307
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 185 | $16,470 | $8,103 | 49.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 124 | $19,840 | $3,792 | 19.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 18 | 40 | $11,200 | $3,537 | 31.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 13 | 55 | $11,000 | $1,602 | 14.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 15 | 62 | $8,060 | $1,570 | 19.5% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 18 | 20 | $8,200 | $1,490 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $1,560 | $1,048 | 67.2% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 18 | 20 | $8,200 | $906.03 | 11.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 13 | 18 | $450.00 | $146.74 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 185 | $16,320 | $8,569 | 52.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 23 | 68 | $13,600 | $2,524 | 18.6% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 11 | 26 | $7,280 | $2,306 | 31.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 23 | 68 | $10,880 | $2,300 | 21.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 22 | 40 | $5,200 | $1,117 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $1,890 | $1,046 | 55.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,440 | $313.08 | 21.7% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 22 | 23 | $1,380 | $274.38 | 19.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 19 | 23 | $575.00 | $156.52 | 27.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 192 | $15,280 | $8,012 | 52.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 15 | 21 | $525.00 | $119.27 | 22.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 180 | $14,400 | $7,217 | 50.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 13 | 13 | $1,560 | $751.56 | 48.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $660.00 | $651.96 | 98.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $2,040 | $576.19 | 28.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $275.00 | $178.42 | 64.9% |
About Sandra Rasbeary, FNP
Sandra Rasbeary, FNP is a Family healthcare provider based in Crosby, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1932491222.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Rasbeary, FNP has received a total of $186.38 in payments from pharmaceutical and medical device companies, with $122.34 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($186.38).
As a Medicare-enrolled provider, Rasbeary has provided services to 619 Medicare beneficiaries, totaling 1,436 services with total Medicare billing of $58,307. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Crosby, TX
- Active Since 05/05/2011
- Last Updated 10/22/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1932491222
Products in Payments
- VRAYLAR (Drug) $64.62
- MOUNJARO (Drug) $41.20
- REXULTI (Drug) $33.44
- Seglentis (Drug) $21.64
- BREZTRI (Drug) $18.34
- Xofluza (Drug) $7.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Crosby
Melissa Dyrdal, Aprn, Cnp, APRN, CNP
Family — Payments: $10,078
Family $10,078
Adam English
Family — Payments: $1,822
Family $1,822
Monica Larson, Fnp-C, FNP-C
Family — Payments: $979.60
Family $979.60
Janie Sova, Fnp-Bc, FNP-BC
Family — Payments: $67.03
Family $67.03
Jesse Oman, Aprn,Cnp, APRN,CNP
Family — Payments: $37.82
Family $37.82
Lindsey Wolff, Np-C, NP-C
Family — Payments: $16.89
Family $16.89